Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 186.38% | -185.74% | -101.46% | -101.46% | 22.59% |
| Total Depreciation and Amortization | 14.52% | 13.22% | 8.70% | 8.70% | 49.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,659.21% | -84.15% | 479.88% | 479.88% | 236.06% |
| Change in Net Operating Assets | 535.81% | 4,194.22% | 171.49% | 171.49% | -312.78% |
| Cash from Operations | -173.24% | -56.42% | -43.89% | -43.89% | -17.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -302.56% | -106.44% | 34.02% | 34.02% | 49.35% |
| Cash from Investing | -302.56% | -106.44% | 34.02% | 34.02% | 49.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 508.52% | 83.80% | 925.81% | 925.81% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 508.52% | 83.80% | 925.81% | 925.81% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,250.84% | 12.89% | 882.91% | 882.91% | 121.99% |